Your browser doesn't support javascript.
loading
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.
Piva, Roberta; Ticconi, Flavia; Ceriani, Valentina; Scalorbi, Federica; Fiz, Francesco; Capitanio, Selene; Bauckneht, Matteo; Cittadini, Giuseppe; Sambuceti, Gianmario; Morbelli, Silvia.
Afiliação
  • Piva R; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa.
  • Ticconi F; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa.
  • Ceriani V; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa.
  • Scalorbi F; Nuclear Medicine Unit, S. Orsola-Malpighi University Hospital, Bologna.
  • Fiz F; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa.
  • Capitanio S; Nuclear Medicine Unit, ASUITS, Trieste.
  • Bauckneht M; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa.
  • Cittadini G; Department of Radiology, IRCCS AOU San Martino - IST.
  • Sambuceti G; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa.
  • Morbelli S; Nuclear Medicine Unit, IRCCS AOU San Martino - IST, Genoa, Italy.
Article em En | MEDLINE | ID: mdl-28740429
ABSTRACT
In the last decades, in addition to conventional imaging techniques and magnetic resonance imaging (MRI), 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has been shown to be relevant in the detection and management of breast cancer recurrence in doubtful cases in selected groups of patients. While there are no conclusive data indicating that imaging tests, including FDG PET/CT, produce a survival benefit in asymptomatic patients, FDG PET/CT can be useful for identifying the site of relapse when traditional imaging methods are equivocal or conflicting and for identifying or confirming isolated loco-regional relapse or isolated metastatic lesions. The present narrative review deals with the potential role of FDG PET in these clinical settings by comparing its accuracy and impact with conventional imaging modalities such as CT, ultrasound, bone scan, 18F-sodium fluoride PET/CT (18F-NaF PET/CT) as well as MRI. Patient-focused perspectives in terms of patients' satisfaction and acceptability are also discussed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article